TET1 protein helps prevent congenital defects and late-onset diseases

May 18, 2017

In the earliest stages of embryonic development, a protein known as TET1 may be the factor that tips the balance toward health or disease. The first evidence for this vital role of TET1 is presented in Nature Genetics by researchers from KU Leuven (University of Leuven), Belgium. They found that TET1 is necessary to prevent congenital defects such as spina bifida as well as mental retardation and cancer later in life.

Every mammal starts off as a cluster of cells with the same genetic material. As the embryo develops, this DNA is used to generate the cell-specific building blocks for lungs, the brain, and every other tissue and organ in the body. To determine which genetic information is needed for a specific cell—and when—chemical marks or methyl groups are added to the DNA at specific positions. Erasing a mark often switches on a specific message, whereas adding a mark usually switches it off. This determines how proteins interpret the .

In 2009, a team of researchers at Harvard University demonstrated that the TET protein family erases marks from the DNA and is thus essential for the proper of the embryo. The precise role of the three family members, however, remained a mystery.

Professor Kian Koh from the KU Leuven Department of Development and Regeneration, who was a co-lead author of the Harvard study, has now been able to shed light on the role of the first family member, TET1. He found that the protein plays a vital role in the embryonic stage that precedes the development of individual organs.

"TET1 is the only TET protein found in detectable amounts at this stage," Professor Koh explains. "This suggests that it has a unique function. To find out which one, we created mice that lack TET1."

"The prevents the incorrect marking of DNA," Professor Koh continues. "We found that the loss of TET1 may lead to severe defects that cause the brain or spinal cord to develop outside the body. The causes of such defects, including , are very complex, of course, but our findings suggest that TET1 plays a pivotal role in preventing them."

But incorrect marking of the DNA may also cause late-onset diseases. "This is because TET1 is necessary to control the speed of . If the timing for the start of a specific stage is off, the foetus may die. And if it survives, the marks on the DNA may still be improperly erased, possibly leading to and cancer later in life."

These findings open up new avenues of research into the origin and prevention of both congenital disorders and various late-onset diseases.

Explore further: Enzyme may be key to cancer progression in many tumors

More information: Rita Khoueiry et al, Lineage-specific functions of TET1 in the postimplantation mouse embryo, Nature Genetics (2017). DOI: 10.1038/ng.3868

Related Stories

Enzyme may be key to cancer progression in many tumors

November 26, 2014

Mutations in the KRAS gene have long been known to cause cancer, and about one third of solid tumors have KRAS mutations or mutations in the KRAS pathway. KRAS promotes cancer formation not only by driving cell growth and ...

TET proteins drive early neurogenesis

December 7, 2016

The fate of stem cells is determined by series of choices that sequentially narrow their available options until stem cells' offspring have found their station and purpose in the body. Their decisions are guided in part by ...

Recommended for you

Gene science closes in on endometriosis

May 25, 2017

In the world's largest study into the genetic causes of endometriosis, University of Queensland researchers have helped identify five new gene regions linked to the disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.